Corient Private Wealth’s Celularity Inc CELUW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$545 Sell
55,000
-57,400
-51% -$654 ﹤0.01% 2822
2025
Q4
$1.83K Buy
112,400
+57,400
+104% +$1.45K ﹤0.01% 2713
2025
Q3
$1.93K Hold
55,000
﹤0.01% 2547
2025
Q2
$2.44K Hold
55,000
﹤0.01% 2430
2025
Q1
$2.2K Hold
55,000
﹤0.01% 2273
2024
Q4
$990 Hold
55,000
﹤0.01% 2342
2024
Q3
$556 Buy
+55,000
New +$946 ﹤0.01% 2455
2023
Q4
Sell
-14,800
Closed -$225 2261
2023
Q3
$225 Buy
+14,800
New +$509 ﹤0.01% 2137
2023
Q2
Sell
-14,800
Closed -$888 2088
2023
Q1
$888 Buy
+14,800
New +$1.23K ﹤0.01% 2002

Other funds holding CELUW

Corient Private Wealth's CELUW Position: Q1 2026 in Review

Corient Private Wealth reduced its Celularity Inc (CELUW) stake by 51% in Q1 2026, selling an estimated $654 and leaving 55,000 shares worth $545. The position accounts for ﹤0.01% of the portfolio, ranked #2822.

Corient Private Wealth first reported a position in CELUW in Q1 2023 and has held it in 9 quarters since. The position peaked at $2.44K in Q2 2025. 14 funds tracked by Wall St. Rank hold CELUW as of Q1 2026.

  • Corient Private Wealth held 55,000 shares of Celularity Inc worth $545 as of Q1 2026.
  • Corient Private Wealth sold 57,400 Celularity Inc shares in Q1 2026, an estimated $654.
  • Celularity Inc made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2822 holding.
  • Corient Private Wealth first reported a position in Celularity Inc in Q1 2023 and has held it in 9 quarters since.
  • Corient Private Wealth's Celularity Inc position peaked at $2.44K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Celularity Inc as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.